Hae-Jun Yang, MinYoung Kim, Young‐Ho Park
In a recent study published in Cell , Kim et al. present a remotely controlled, electromagnetic field (EMF)-inducible gene switch, termed the Ei switch, that enables precise spatiotemporal activation of transgene expression in vivo without pharmacological agents or invasive procedures. 1 By engineering a 450-bp EMF-responsive DNA element (Ei) derived from the leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) promoter, the authors established a transcriptional platform selectively responsive to extremely low-frequency EMF (EL-EMF) under the tested conditions, offering a non-invasive and reversible mode of gene regulation with the potential to address key limitations of optogenetics (limited tissue penetration) and reduce reliance on pharmacological inducers such as tetracycline-responsive systems. 1 , 2 , 3